Global Lyme Disease Diagnostics Market Report and Forecast 2025-2034

Lyme Disease Diagnostics: Introduction and Insights

Lyme disease, also known as Lyme borreliosis, is an infectious disease which is caused due to a bacteria called Borrelia and is carried by ticks, especially blacklegged ticks. The most common indications and symptoms of the condition include erythema migrans, which are rapidly spreading red rashes. These symptoms or indications usually show up a week post the tick bite. The diagnostic tests of the condition include serological test, immunofluorescence (IFA), polymerase chain reaction (PCR) testing, and lymphocyte transformation test, among others.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Timely diagnosis of Lyme disease is extremely important, if left untreated, Lyme disease can intensify and effect different organs of the body and cause further symptoms like headaches and joint/body pain, among other issues.

Key Trends in the Lyme Disease Diagnostics Market

The growth of the market is primarily driven the rising prevalence of Lyme disease across the globe, with the United States alone registering nearly 400,000 cases every year. Other than the rising prevalence, the growth of the market is also driven by the rapid growth in technological advancements, like immunoassay techniques, Next-Generation Sequencing (NGS), and PCR, among others.

The growth of the market can also be attributed to the rising healthcare expenditure by the government and private organisations. The are investing more into the development of diagnostic centres and healthcare facilities. Various organisations are also taking initiatives to further raise the awareness about the disease and the available treatments. The rising investment and funding by the government and different corporations has been contributing significantly to the growth of the market.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global Lyme Disease Diagnostics Market Segmentation

Global Lyme Disease Diagnostics Market Scenario

Based on diagnostic technology, the serological test is anticipated to lead the global market owing to the higher efficiency of the test as compared to the other types.

Among the regional market, North America is anticipated to lead the global Lyme disease diagnostics market owing to the rising prevalence of the disease within the region. The region is anticipated to continue bolstering the global market owing to the increasing awareness about the condition and the importance of timely treatment. Better technologies are enabling enhanced diagnosis of the condition, which is likely to aid the growth of the market further in the forecast period.

Europe and Asia Pacific are also witnessing higher number of infections and are likely to witness growth in the coming years due to the rising awareness and the rising development of the healthcare infrastructure in the region.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Competitive Landscape

The comprehensive EMR report provides an in-depth assessment of the market based on Porter's five forces model, along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global Lyme disease diagnostics market, covering their competitive landscape and the latest developments like mergers, acquisitions, investments, and expansion plans.

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.

• Abbott Laboratories
• Bio-Rad Laboratories
• Covance Inc.
• Fres F. Hoffmann-La Roche AG
• T2 Biosystems
• Oxford Immunotec
• Baxter
• Fresenius Medical Care
• Bolder Biotechnology, Inc.
• Roche Holding AG
• Siemens AG
• Immunetics Inc
• GlaxoSmithKline Pharmaceuticals
• Canon Lifesciences
• Covance